Eko Low Ejection Fraction Tool (ELEFT) vs Study Watch with Irregular Pulse Monitor (Home)

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AI Verdict

Tool A, the Eko Low Ejection Fraction Tool, is designed for in-clinic screening of low ejection fraction using a digital stethoscope, aiding in early heart failure detection during routine exams. In contrast, Tool B, the Verily Study Watch, is a wearable device focused on remote, unobtrusive physiological data collection, including irregular pulse monitoring for atrial fibrillation, primarily for clinical research and prescription use. While both leverage AI for cardiac insights and are FDA-cleared, their distinct deployment methods and primary target conditions make them complementary rather than direct competitors.

Choose Eko Low Ejection Fraction Tool (ELEFT) if…

Choose Eko Low Ejection Fraction Tool (ELEFT) if you need a rapid, non-invasive screening tool to aid in the early detection of low ejection fraction during routine physical examinations. This tool is ideal for clinicians seeking to quickly assess heart failure risk at the point of care using their Eko digital stethoscope.

View Eko Low Ejection Fraction Tool (ELEFT) →

Choose Study Watch with Irregular Pulse Monitor (Home) if…

Choose Verily Study Watch with Irregular Pulse Monitor (Home) if you require a prescription-only wearable for continuous, long-term remote physiological data collection in clinical research or for monitoring patients for irregular heart rhythms like AFib. This device is best suited for unobtrusive, extended data capture and advanced cloud-based analytics beyond a single point-of-care assessment.

View Study Watch with Irregular Pulse Monitor (Home) →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Eko Low Ejection Fraction Tool (ELEFT)

Eko Low Ejection Fraction Tool (ELEFT) integrates seamlessly into routine physical exams, providing results in approximately 15 seconds using a familiar stethoscope. This makes it highly usable within existing clinical workflows. The Verily Study Watch, while unobtrusive, is a wearable device that requires patient adherence and potentially more management for the patient and clinician for ongoing monitoring.

Clinical Value

Eko Low Ejection Fraction Tool (ELEFT)

Both tools are FDA-cleared and address significant cardiac conditions. ELEFT offers early detection of low ejection fraction, a key indicator of heart failure, directly during a routine physical exam, which is crucial for proactive screening. The Verily Study Watch focuses on irregular pulse monitoring for AFib and broader physiological data collection for research and ongoing monitoring, which is valuable but less focused on immediate screening for a critical condition in a primary care setting.

Pricing & Value

Tie

Both tools require direct contact for pricing, and neither provides publicly available pricing details. Without specific cost information or a clear understanding of the full scope of their respective enterprise offerings, it is not possible to definitively determine which provides better value.

Enterprise Readiness

Eko Low Ejection Fraction Tool (ELEFT)

ELEFT is explicitly positioned as part of Eko's SENSORAu2122 platform, an enterprise solution, and clearly states it is HIPAA compliant with a Business Associate Agreement (BAA). While Verily also offers a BAA and states its services may be subject to HIPAA, a reported lawsuit alleging past HIPAA breaches raises a potential concern regarding its historical enterprise readiness, even if current compliance is asserted.

Innovation

Tie

ELEFT demonstrates innovation by integrating AI-powered low ejection fraction detection into a standard stethoscope, offering rapid diagnostic insights during a routine physical. The Verily Study Watch is innovative through its comprehensive suite of physiological and environmental sensors, long battery life, and secure, continuous data collection in a wearable form factor, enabling extensive monitoring and research capabilities. Both represent significant advancements in their respective applications.

Support & Docs

Eko Low Ejection Fraction Tool (ELEFT)

Eko Health provides a comprehensive online Help Center with user manuals, FAQs, troubleshooting guides, and direct contact options for customer support, catering to both individual and enterprise customers. Verily Study Watch documentation is primarily geared towards clinical research and technical specifications, with less readily available direct user support resources for clinicians or patients in a general healthcare setting.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Eko Low Ejection Fraction Tool (ELEFT) Study Watch with Irregular Pulse Monitor (Home)
Tool Name Eko Low Ejection Fraction Tool (ELEFT) Study Watch with Irregular Pulse Monitor (Home)
Company Eko Health Verily Life Sciences LLC
Primary Detection/Monitoring AI-powered low ejection fraction detection, aids in early identification of heart failure risk. On-demand single-channel ECG measurement, irregular pulse monitoring for atrial fibrillation (AFib) detection.
Device Type AI algorithm integrated with digital stethoscopes. Wearable device (Study Watch).
Prescription Requirement Not specified Prescription-only
Key Data Analyzed/Sensors Analyzes ECG and heart sound recordings. On-demand single-channel ECG, irregular pulse monitoring, multiple physiological sensors (heart rate, electrodermal activity, inertial movements), environmental sensors.

Videos

Demos, reviews, and walkthroughs featuring Eko Low Ejection Fraction Tool (ELEFT) and Study Watch with Irregular Pulse Monitor (Home).

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

The Eko Low Ejection Fraction Tool (ELEFT) integrates with digital stethoscopes for rapid, non-invasive screening during routine physical exams, providing results in approximately 15 seconds, allowing for immediate clinical decision-making. The Verily Study Watch is a wearable designed for continuous, unobtrusive data collection for longer-term monitoring and clinical research, with data often reviewed by a cardiographic technician before physician reporting.
ELEFT demonstrated a sensitivity of 74.7% and specificity of 77.5% for detecting Left Ventricular Ejection Fraction (LVEF) u226440% in a large clinical study. The Verily Study Watch showed high accuracy for AF detection, with 96.1% sensitivity and 98.1% specificity for interval-level AF detection in a study of patients at risk for AF events.
Eko's SENSORA platform integrates with EHRs, enabling clinicians to open the dashboard within their system and push results as PDF reports or anonymous URLs directly into the patient's chart. Verily's platform (Pre) is designed to integrate multimodal data, including wearable sensor data and traditional EHR data, to provide a comprehensive view for clinical research and potentially inform future clinical care.
Eko's SENSORA platform is designed for easy integration and rapid training for clinical staff, with surveyed users reporting it as easy to use and valuable, and Eko provides a help center, support, and live demos. Verily offers comprehensive support, including high-touch assistance from clinical, scientific, technology, and regulatory leaders, dedicated program managers, and around-the-clock technical and participant support for its research-focused device.
ELEFT is best suited for primary care and emergency settings to screen at-risk patients (e.g., with coronary artery disease, diabetes, hypertension) for low ejection fraction during routine physical exams, with deployments at hospitals like Wayne General. The Verily Study Watch is a prescription-only device primarily for clinical research, monitoring adult patients aged 22+ for irregular pulse/AFib, and has been used in large longitudinal studies like Project Baseline across diverse populations.
Eko's SENSORA platform is an enterprise solution designed for health systems, with demonstrated multi-site deployments in primary care and emergency settings, including over 100 practices in the UK. The Verily Study Watch is built for scalable data collection in large clinical and observational studies, offering global deployment capabilities and expert support for multi-center research initiatives.

Backers

Who funded each tool's parent company.

Study Watch with Irregular Pulse Monitor (Home)

AI Tool Finder
AI-powered search. Results may not be comprehensive.